BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 25173088)

  • 1. Controlled transdermal delivery of leuprorelin by pulsed iontophoresis and ion-exchange fiber.
    Malinovskaja K; Laaksonen T; Hirvonen J
    Eur J Pharm Biopharm; 2014 Nov; 88(3):594-601. PubMed ID: 25173088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers.
    Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L
    Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To enhance the efficiency of nefopam transdermal iontophoresis by using a novel method based on ion-exchange fiber.
    Xin C; Lihong W; Fei H; Yan W; Qifang W; Yang Y; Yue Y; San-ming L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):9-16. PubMed ID: 23317337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion-exchange and iontophoresis-controlled delivery of apomorphine.
    Malinovskaja K; Laaksonen T; Kontturi K; Hirvonen J
    Eur J Pharm Biopharm; 2013 Apr; 83(3):477-84. PubMed ID: 23207323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled transdermal iontophoresis by ion-exchange fiber.
    Jaskari T; Vuorio M; Kontturi K; Urtti A; Manzanares JA; Hirvonen J
    J Control Release; 2000 Jul; 67(2-3):179-90. PubMed ID: 10825552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tramadol loading, release and iontophoretic characteristics of ion-exchange fiber.
    Gao Y; Yuan J; Liu H; Yang Y; Hou Y; Li S
    Int J Pharm; 2014 Apr; 465(1-2):102-11. PubMed ID: 24530391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro transdermal iontophoretic delivery of leuprolide under constant current application.
    Kochhar C; Imanidis G
    J Control Release; 2004 Jul; 98(1):25-35. PubMed ID: 15245886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
    Dubey S; Kalia YN
    J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
    Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir.
    Xu Q; Ibrahim SA; Higuchi WI; Li SK
    Int J Pharm; 2009 Mar; 369(1-2):105-13. PubMed ID: 19041698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amino acid sequence on transdermal iontophoretic peptide delivery.
    Schuetz YB; Naik A; Guy RH; Kalia YN
    Eur J Pharm Sci; 2005 Dec; 26(5):429-37. PubMed ID: 16143501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro transdermal iontophoretic delivery of leuprolide-mechanisms under constant voltage application.
    Kochhar C; Imanidis G
    J Pharm Sci; 2003 Jan; 92(1):84-96. PubMed ID: 12486685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal delivery of peptides by iontophoresis.
    Hirvonen J; Kalia YN; Guy RH
    Nat Biotechnol; 1996 Dec; 14(13):1710-3. PubMed ID: 9634857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
    Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
    Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal iontophoretic delivery of triptorelin in vitro.
    Schuetz YB; Naik A; Guy RH; Vuaridel E; Kalia YN
    J Pharm Sci; 2005 Oct; 94(10):2175-82. PubMed ID: 16136544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin.
    Juluri A; Narasimha Murthy S
    J Control Release; 2014 Sep; 189():11-8. PubMed ID: 24950431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
    Gratieri T; Kalia YN
    Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal iontophoretic delivery of vapreotide acetate across porcine skin in vitro.
    Schuetz YB; Naik A; Guy RH; Vuaridel E; Kalia YN
    Pharm Res; 2005 Aug; 22(8):1305-12. PubMed ID: 16078140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.